|
Volumn 26, Issue 3, 2010, Pages 301-305
|
Short communication: Evaluation of the effect of enfuvirtide in 11 HIV-1 vertically infected pediatric patients outside clinical trials
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
ATAZANAVIR;
DARUNAVIR;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
ENFUVIRTIDE;
ETRAVIRINE;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
RITONAVIR;
SAQUINAVIR;
TENOFOVIR;
TIPRANAVIR;
VIRUS RNA;
ADOLESCENT;
ADULT;
ARTICLE;
CD4 LYMPHOCYTE COUNT;
CHILD;
CLINICAL ARTICLE;
FEMALE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
INJECTION SITE CONTUSION;
INJECTION SITE EDEMA;
INJECTION SITE ERYTHEMA;
INJECTION SITE INDURATION;
INJECTION SITE PAIN;
INJECTION SITE REACTION;
INJECTION SITE SWELLING;
MALE;
PRESCHOOL CHILD;
PRIORITY JOURNAL;
SCHOOL CHILD;
TREATMENT FAILURE;
TREATMENT RESPONSE;
VERTICAL TRANSMISSION;
VIREMIA;
VIRUS LOAD;
ADOLESCENT;
CHILD;
DRUG RESISTANCE, MULTIPLE, VIRAL;
DRUG THERAPY, COMBINATION;
HIV ENVELOPE PROTEIN GP41;
HIV FUSION INHIBITORS;
HIV INFECTIONS;
HIV PROTEASE INHIBITORS;
HIV-1;
HUMANS;
INFECTIOUS DISEASE TRANSMISSION, VERTICAL;
PEPTIDE FRAGMENTS;
PYRIDAZINES;
PYRIDINES;
PYRONES;
SULFONAMIDES;
TIME FACTORS;
TREATMENT OUTCOME;
YOUNG ADULT;
|
EID: 77950233376
PISSN: 08892229
EISSN: None
Source Type: Journal
DOI: 10.1089/aid.2009.0151 Document Type: Article |
Times cited : (8)
|
References (10)
|